Anne Wojcicki Partner

Wojcicki ‘Committed’ to Taking 23andMe Private as Board Quits

(Bloomberg) -- 23andMe Holding Co. co-founder and Chief Executive Officer Anne Wojcicki told employees that she remains committed to taking the genetic testing company private following the resignation of its independent board members.

New York Post · 3d

23andMe independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private

All seven of 23andMe’s independent board members resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the company private. Wojcicki, who has been trying to take the company private since April, proposed to acquire all outstanding shares of 23andMe not owned by her or her affiliates for $0.40 per share, in July.

MarketWatch on MSN · 3d

23andMe’s independent directors quit in clash with CEO over buyout plan

The directors said the decision comes after months of work that failed to result in an actionable plan that meets the interests of non-affiliated shareholders.

2don MSN

Celebrities, CEOs, and sports stars pile into $5 million fundraise for Midi Health, a startup providing menopause care

Midi has raised $103 million in total funding to provide virtual health care to middle-aged women.

What the Fed’s Big Rate Cut Reveals About the Economy

Investors have sent stocks and bonds higher on expectations of a soft landing. But some Republicans think the central bank ...

NBC New York1mon

Former YouTube CEO Susan Wojcicki dies at 56

“Susan was not just my best friend and partner in life, but a brilliant mind ... San Francisco. Her other sister is Anne Wojcicki. CEO of 23andMe. Most recently, Wojcicki and Troper's son ...

2dIn Depth

Exclusive: Avid Ventures raises $87 million second fund

Avid Ventures has raised $87 million for its second fund, Fortune can exclusively report.

Scientific American2d

Was Thalidomide Safe? Frances Oldham Kelsey Was Not Convinced

In the U.S. in the early 1960s the distributor of a thalidomide drug was impatient to get it on the market. But FDA medical ...

Investing on MSN3d

Landmark Fed decision in focus, futures edge higher - what's moving markets

US stock futures tick higher ahead of an all-important Federal Reserve interest rate decision on Wednesday, with debate ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results